Mayer Arie - Insider Non-Derivative Transactions at ORAMED PHARMACEUTICALS INC. (ORMP) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jun 5, 2025, Mayer Arie's relationship to ORAMED PHARMACEUTICALS INC. (ORMP) is Director, and currently has 133,109 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ORMP insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Mayer Arie - Insider Non-Derivative Transactions of ORMP Common Stock

Mayer Arie - Insider Non-Derivative Transactions at ORMP

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Jun 6, 2025	Acquisition -- (Common Stock)	30000	0	126134
Jun 6, 2025	Acquisition -- (Common Stock)	6975	0	133109
Jan 5, 2024	Acquisition -- (Common Stock)	30000	0	86809
Jan 5, 2024	Acquisition -- (Common Stock)	9325	0	96134
Apr 18, 2023	Acquisition -- (Common Stock)	30000	0	56809
Apr 5, 2023	P -- (Common Stock)	3800	2.21	26809
Apr 4, 2023	P -- (Common Stock)	5009	2.22	23009